Optimization and Clinical Study of Early Prediction Model for Neonatal Acute Respiratory Distress Syndrome

Sponsor
University-Town Hospital of Chongqing Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05647850
Collaborator
(none)
2,000
36

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about neonatal acute respiratory distress syndrome in describe participant population. The main question it aims to answer is: using perinatal factors to predict early neonatal acute respiratory distress syndrome and reduce its mortality.

Participants' umbilical cord blood will be collected for testing, but will not receive any intervention.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Study Design

Study Type:
Observational
Anticipated Enrollment :
2000 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Optimization and Clinical Study of Early Prediction Model for Neonatal Acute Respiratory Distress Syndrome
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Baseline characteristics of all patients

Other: No intervention
No intervention

General characteristics of the patients.

Other: No intervention
No intervention

Outcome Measures

Primary Outcome Measures

  1. General characteristics of the patients [2023.1-2025.12]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Minute and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • A newborn born alive
Exclusion Criteria:
  • Stillborn newborn

  • Respiratory distress syndrome(RDS), transient tachypnoea of the neonate (TTN), or congenital anomalies as a primary current acute respiratory condition

  • Hereditary endocrine and metabolic diseases

  • Incomplete records

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University-Town Hospital of Chongqing Medical University

Investigators

  • Principal Investigator: Hui Liu, University-Town Hospital of Chongqing Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hui Liu, Attending physician, University-Town Hospital of Chongqing Medical University
ClinicalTrials.gov Identifier:
NCT05647850
Other Study ID Numbers:
  • 123456
First Posted:
Dec 13, 2022
Last Update Posted:
Dec 14, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hui Liu, Attending physician, University-Town Hospital of Chongqing Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 14, 2022